How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,145 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Overview of pregnancy complications

Obstet Gynecol. 2000;183:S1-S22. http://www.ncbi.nlm.nih.gov/pubmed/10920346?tool=bestpractice.com Pre-eclampsia is usually asymptomatic but may present with headache, seizure, blurred vision, and abdominal pain. Risk factors include nulliparity (or first pregnancy with new partner), family history of pre-eclampsia, body mass index >30, maternal age >35 years, and multiple (twin) pregnancy. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension (...) Overview of pregnancy complications Overview of pregnancy complications - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of pregnancy complications Last reviewed: February 2019 Last updated: September 2018 Introduction Complications in pregnancy can result from conditions that are specifically linked to the pregnant state as well as conditions that commonly arise or occur incidentally in women who are pregnant

2018 BMJ Best Practice

102. Molar pregnancies

). Gestational trophoblastic disease includes tumours of fetal tissues, including hydatidiform moles, arising from placental trophoblasts. Syncytiotrophoblasts secrete human chorionic gonadotrophin and, therefore, this hormonal product is used as a tumour marker for the disease. History and exam presence of risk factors first trimester of pregnancy missed period vaginal bleeding unusually large uterus for gestational age headache and photophobia shortness of breath and respiratory distress severe nausea (...) Molar pregnancies Molar pregnancies - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Molar pregnancies Last reviewed: February 2019 Last updated: March 2018 Summary Chromosomally abnormal pregnancies that have the potential to become malignant. Higher possibility of gestational trophoblastic disease (GTD) for women less than 20 years of age or over 35 years of age, and in those who have experienced GTD in a previous

2018 BMJ Best Practice

103. Nausea and vomiting in pregnancy

Nausea and vomiting in pregnancy Nausea and vomiting in pregnancy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Nausea and vomiting in pregnancy Last reviewed: February 2019 Last updated: March 2018 Summary Affects approximately 75% of pregnant women. Typically begins between the fourth and seventh week after the last menstrual period and resolves in the second trimester. Aetiology remains unclear. There is some (...) trophoblastic disease other causes of increased placental mass female fetus history of motion sickness history of migraine headache Diagnostic investigations full blood count basic metabolic panel serum liver function tests serum urea and creatinine serum thyroid-stimulating hormone (TSH) and free T4 urinalysis urine or serum ketones fetal ultrasound with nuchal translucency serum analytes Helicobacter pylori breath test urine culture serum amylase and lipase RUQ ultrasound renal ultrasound cranial CT

2018 BMJ Best Practice

104. Overview of pregnancy complications

Obstet Gynecol. 2000;183:S1-S22. http://www.ncbi.nlm.nih.gov/pubmed/10920346?tool=bestpractice.com Pre-eclampsia is usually asymptomatic but may present with headache, seizure, blurred vision, and abdominal pain. Risk factors include nulliparity (or first pregnancy with new partner), family history of pre-eclampsia, body mass index >30, maternal age >35 years, and multiple (twin) pregnancy. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension (...) Overview of pregnancy complications Overview of pregnancy complications - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of pregnancy complications Last reviewed: February 2019 Last updated: September 2018 Introduction Complications in pregnancy can result from conditions that are specifically linked to the pregnant state as well as conditions that commonly arise or occur incidentally in women who are pregnant

2018 BMJ Best Practice

105. Assessment of abdominal pain in pregnancy

Assessment of abdominal pain in pregnancy Assessment of abdominal pain in pregnancy - Differential diagnosis of symptoms | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Assessment of abdominal pain in pregnancy Last reviewed: February 2019 Last updated: June 2018 Summary Abdominal pain throughout pregnancy is common. Many adaptive or physiological changes of pregnancy affect the presentation. Women tend to visit doctors often as they are concerned (...) about the health of their fetus. Patients require a careful assessment in order to reduce anxiety and give reassurance. If the clinical picture is unclear, a specialist should be consulted. Chamberlain G. ABC of antenatal care: abdominal pain in pregnancy. BMJ. 1991;302:390-1394. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1670063/pdf/bmj00129-0073.pdf http://www.ncbi.nlm.nih.gov/pubmed/2059722?tool=bestpractice.com Augustin G, Majerovic M. Non-obstetrical acute abdomen during pregnancy. Eur J

2018 BMJ Best Practice

106. Hypertension in pregnancy: Scenario: Postpartum follow-up for hypertensive disorders in pregnancy

for referral to primary care for blood pressure review Advice on self-monitoring for symptoms of . All women with pre-eclampsia: Should be assessed for symptoms of (particularly severe headache and epigastric pain) at each consultation. Who are discharged to primary care with abnormal blood results should have repeat blood tests to measure platelet count, transaminases, and serum creatinine as clinically indicated, until results return to normal. Women with pre-eclampsia who did not take antihypertensive (...) with suspected postpartum pre-eclampsia or eclampsia should be admitted to hospital for immediate assessment. Consider the possibility of imminent pre-eclampsia or eclampsia in a woman up to 4 weeks postpartum (even if she has not had previous hypertension or pre-eclampsia) if she develops any of the following: Severe headaches (increasing frequency unrelieved by regular analgesics). Visual problems, such as blurred vision, flashing lights, double vision, or floating spots. Persistent new epigastric pain

2020 NICE Clinical Knowledge Summaries

107. Management of Cardiovascular Diseases during Pregnancy Full Text available with Trip Pro

dissection, and myocardial infarction (MI) were the most common causes of maternal death in the UK over the period 2006–08. Knowledge of the risks associated with CVDs during pregnancy and their management in pregnant women who suffer from serious pre-existing conditions is of pivotal importance for advising patients before pregnancy. Since all measures concern not only the mother but the foetus as well, the optimum treatment of both must be targeted. A therapy favourable for the mother can be associated (...) Management of Cardiovascular Diseases during Pregnancy We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close

2018 European Society of Cardiology

108. PRAC recommends new measures to avoid valproate exposure in pregnancy

, with the details to be adapted at national level. A patient reminder card will also be attached to the outer package for pharmacists to discuss with the patient each time the medicine is dispensed. Companies that market valproate should also provide updated educational materials in the form of guides for healthcare professionals and patients. What are the main points of the new valproate pregnancy prevention programme? Assessing patients for the potential of becoming pregnant, and involving the patient (...) PRAC recommends new measures to avoid valproate exposure in pregnancy PRAC recommends new measures to avoid valproate exposure in pregnancy | European Medicines Agency Search Search Menu PRAC recommends new measures to avoid valproate exposure in pregnancy Press release 09/02/2018 New restrictions on use; pregnancy prevention programme to be put in place The European Medicines Agency's experts in medicines safety, the ( ) are recommending new measures to avoid exposure of babies to valproate

2018 European Medicines Agency - EPARs

109. Treating Opioid Use Disorder During Pregnancy: Guideline Supplement

of Family Medicine, St. Joseph’s Health Center, Toronto Launette Rieb, MD, MSc, CCFP , FCFP , Dip. ABAM, CCSAM; Medical Consultant, St Paul’s Hospital; Physician, Orchard Recovery Centre; Physician, Orion Health (Vancouver Pain Clinic); Clinical Associate Professor, University of British Columbia 6 Acknowledgements The Pregnancy Supplement Development Committee would like to thank Dr. Peter Blanken, Dr. Scott MacDonald, Dr. Hans-Guenter Meyer-Thompson, and Dr. Marc Vogel for their expert guidance (...) represent the view of the Pregnancy Supplement Committee, arrived at after careful consideration of the available scientific evidence and external expert peer review. When treating pregnant patients with opioid use disorder, health care professionals are expected to consider this guideline supplement alongside the recommendations articulated in A Guideline for the Clinical Management of Opioid Use Disorder. These guidelines should be considered and interpreted in the context of the individual needs

2018 British Columbia Perinatal Health Program

110. New measures to avoid valproate exposure in pregnancy endorsed

the conditions of a new pregnancy prevention programme are met. The programme is designed to ensure that patients are made fully aware of the risks and the need to avoid becoming pregnant. A visual warning of the pregnancy risks (in the form of boxed text with other possible elements such as a warning symbol) must also be placed on the packaging of the medicines and warnings be included on patient cards attached to the box and supplied with the medicine each time it is dispensed. The agreed with EMA's (...) : an assessment of each patient's potential for becoming pregnant, pregnancy tests before starting and during treatment as needed, counselling about the risks of valproate treatment and the need for effective contraception throughout treatment, a review of ongoing treatment by a specialist at least annually, introduction of a new risk acknowledgement form that patients and prescribers will go through at each such annual review to confirm that appropriate advice has been given and understood. As before

2018 European Medicines Agency - EPARs

111. Clinical practice guideline for the care of women with decreased fetal movements for women with a singleton pregnancy from 28 weeks’ gestation

Clinical practice guideline for the care of women with decreased fetal movements for women with a singleton pregnancy from 28 weeks’ gestation Clinical practice guideline for the care of women with decreased fetal movements for women with a singleton pregnancy from 28 weeks’ gestation Endorsed by: Version 2.3 September 2019 i Produced by: This is the third version of the clinical guideline produced by a multidisciplinary working group led by the Centre of Research Excellence in Stillbirth (...) Australia; Australian National Council for Stillbirth and Neonatal Death Support (SANDS); Red Nose; Women’s Healthcare Australasia; and Still Aware. Suggested citation: Perinatal Society of Australia and New Zealand and Centre of Research Excellence Stillbirth. Clinical practice guideline for the care of women with decreased fetal movements for women with a singleton pregnancy from 28 weeks’ gestation. Centre of Research Excellence in Stillbirth. Brisbane, Australia, September 2019. Acknowledgments: We

2019 Centre of Research Excellence in Stillbirth

112. Headache-Related Neuroimaging

Neuroimaging Headache-Related Neuroimaging Aka: Headache-Related Neuroimaging , Neuroimaging in Headache II. Indications s III. Protocol: Imaging selection Immunocompromised with and without contrast suspected in age >60 years with and without contrast Requires starting s and obtaining temporal artery biopsy Suspected or without contrast Start antibiotics and obtain Pregnancy and severe (preferred) or Suspected carotid dissection with severe unilateral with and without contrast and MRA of the head and neck (...) Headache-Related Neuroimaging Headache-Related Neuroimaging Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Headache-Related

2018 FP Notebook

113. Headache Red Flag

Headache Red Flag Headache Red Flag Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Headache Red Flag Headache Red Flag Aka: Headache (...) Asymmetric motor function Abnormal Onset recently or suddenly Onset after age 40 years Prior that is different or progressive Different location is less useful as predictor of serious cause Pain response to standard therapy is not predictive of serious cause References Dodick (2003) Adv Stud Med S550-5 VI. References Edlow and Weinstock (2013) EM:Rap 13(12): 7-8 Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Headache Red Flag." Click

2018 FP Notebook

114. Migraine Headache Prophylaxis

Migraine Headache Prophylaxis Migraine Headache Prophylaxis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Migraine Headache (...) Prophylaxis Migraine Headache Prophylaxis Aka: Migraine Headache Prophylaxis , Migraine Prophylaxis From Related Chapters II. Epidemiology Of the 38% of episodic patients in whom prophylaxis is indicated, less than half are taking prophylaxis III. Indications: Frequent Migraine Headaches frequency s per month: 4 or more OR days per month: 8 or more Consider in any patient desiring Migraine Prophylaxis to reduce frequency duration Prolonged s >2 days with response to Debilitating despite acute abortive

2018 FP Notebook

115. Bacterial vaginosis in pregnancy and risk of spontaneous preterm delivery

The objective of this guideline is to evaluate bacterial vaginosis in pregnancy concerning • Different treatments for prevention of preterm delivery. • Screening of pregnant women with low as well as high risk of sPTD. • Stratification into gestational ages below and above 16 weeks. • Diagnostic methods. Key words Bacterial vaginosis, vaginal pH, pH-glove, vaginal discharge, Nugent score, Amsel score, Gardnerella vaginalis, Mobiluncus species, preterm delivery, preterm birth, GRADE, clindamycin (...) , clindamycin might be used for treatment of symp- toms). • This recommendation addresses both treatment with metronidazole and clindamycin. • This recommendation addresses all gestational ages of pregnancy. Treatment with probiotics ??: We suggest against treatment of BV-positive pregnant women with probiotics in order reducing the risk of sPTD. • This recommendation addresses both women at low and high risk of sPTD. • This recommendation addresses asymptomatic as well as symptomatic women

2019 Nordic Federation of Societies of Obstetrics and Gynecology

116. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic Full Text available with Trip Pro

on OUD in particular; to draft preliminary recommendations regarding screening, pain management, and medication-assisted therapy (MAT) for OUD during pregnancy; and to delineate research gaps. Epidemiology of opioid use in pregnancy Epidemiologic evidence that was presented at the workshop demonstrated that rates of substance use in pregnancy have increased significantly in the past decade and that rates of OUD in pregnant and postpartum women have increased in parallel: • One study reported (...) on epidemiology, prenatal screening, pain management, and treatment modalities of OUD in pregnancy, workshop participants were assigned to 1 of 3 breakout groups to discuss the following key issues in greater depth and to make preliminary recommendations: (1) screening and testing for substance use disorder, including OUD, in pregnancy; (2) pain management during the antepartum, intrapartum, and postpartum periods; and (3) management modalities for pregnant women with OUD. The following key findings emerged

2019 Society for Maternal-Fetal Medicine

117. UK guidelines on the management of iron deficiency in pregnancy Full Text available with Trip Pro

is required for fetal growth and development (Scholl, ), as well as for increased maternal erythropoiesis (Bothwell, ; Fisher & Nemeth, ). The current Hb thresholds defining anaemia in pregnancy are based on historical normal values derived from non‐pregnant populations, which are not clearly linked to clinical outcomes and there is ongoing debate as to the applicability of these values (Pasricha et al , ). The WHO is reviewing the evidence relating to the Hb below which anaemia should be defined (WHO (...) period are recognised as a critical period where there is rapid brain development, high neural plasticity and high nutritional requirement (Gluckman & Hanson, ; Georgieff et al , ). Animal studies show maternal iron deficiency late in pregnancy is associated with neurodevelopmental impairment. Observational studies in pregnant women have found that iron deficiency anaemia late in pregnancy is associated with premature birth and low Apgar score (<5 at 1 min) (Lone et al , ), and impaired motor

2019 British Committee for Standards in Haematology

118. Syphilis in pregnancy

, and cytokines, leading to an acute inflammatory response 24 · More common during treatment for infectious syphilis 24 due to high bacterial burden 31 · Case studies report JHR occurs in up to 44% of pregnant women treated for syphilis 44,45 · Concerns about JHR relevant only to the first dose of treatment Symptoms · Onset within 2–12 hours post treatment and lasts several hours 44 · Usually self-limiting 44,46 resolving by 24 hours after treatment 24 · Fever, headaches, rigors, joint pain chills, malaise (...) reduction · Early screening of all pregnant women, and identification of high risk pregnancies and babies can prevent adverse perinatal outcomes 15,16 Queensland Clinical Guideline: Syphilis in pregnancy Refer to online version, destroy printed copies after use Page 9 of 31 1.4 Notifiable disease Table 3. Disease notification Aspect Consideration Context · Syphilis is a controlled notifiable disease in Queensland as per the Public Health Act (2005) 19 · Routine reporting is the cornerstone of syphilis

2019 Queensland Health

119. A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective.

A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective. A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective. (MAD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02295280 Recruitment Status : Completed First Posted : November 20, 2014 Results First Posted : April 2, 2018 Last

2014 Clinical Trials

120. CRACKCast E178 – Co-Morbird Medical Emergencies During Pregnancy

(eg, shortness of breath, mild chest pain, edema) can be seen in normal pregnancies, these entities are especially difficult to diagnose. Chronic hypertension is defined as hypertension (>140 mm Hg systolic or >90 mm Hg diastolic) diagnosed prior to pregnancy or before 20 weeks’ gestation. The key question in the ER is: Does that patient have any end organ dysfunction? (head, eyes, heart, lungs, liver, kidney, bone marrow) Medical treatment of uncomplicated chronic hypertension in pregnancy (...) are all more common than myocardial ischemia during pregnancy and should be considered in the differential diagnosis of the pregnant patient who presents with chest pain. [3] How is maternal Hepatitis B managed in the peripartum period? What treatments are indicated for the fetus? Perinatal transmission is approximately 10% to 20% in women seropositive for HBV surface antigen (HBsAg) alone but approaches 90% in mothers who are seropositive for HBsAg and HBV envelope antigen (HBeAg); it is also more

2018 CandiEM

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>